Novel approaches to the comprehensive assessment of the quality and adherence to pharmacotherapy and its use in cardiovascular patients

Author:

Lukina Yu. V.1ORCID,Kutishenko N. P.1ORCID,Martsevich S. Yu.1ORCID,Drapkina O. M.1ORCID

Affiliation:

1. National Medical Research Center for Therapy and Preventive Medicine

Abstract

Aim. To assess quality and adherence to pharmacotherapy (PT) based on the developed integrated indicators in a cohort of outpatients with stable exertional angina.Material and methods. Using the expert evaluation method for main parameters of quality and compliance to PT, formulas were developed for calculating integrated indicators — the quality factor of PT (QFPT) and the rational PT index (RPTI). QFPT and RPTI are measured as a percentage; if the value is less than 50%, the parameters determined by them are considered unsatisfactory. In a cohort of 590 patients with stable exertional angina (men, 55,8%; mean age, 65,1±9,6 years), QFPT and RPTI were calculated. To assess the quality parameters of PT, data from patient registration forms were used, while adherence was determined using a 4-question validated score. After 21-month follow-up, primary composite endpoint was assessed: all-cause death, cardiovascular evens; an analysis of adverse outcomes was performed depending on QFPT and RPTI values.Results. In patients with exertional angina, QFPT of 0% was determined in 8 (1,4%) people, while every sixth patient (16,4%) received unsatisfactory PT (QFPT <50%). In the majority of patients (419 (82,4%) people), RPTI was less than 50%. In subgroups of patients with RPTI <50% and >50%, there was a significant difference in the Kaplan-Meier survival curves, according to the log-rank test (p=0,006). The hazard ratio (RR) in the Cox regression model showed a threefold significant increase in the risk of adverse outcomes with RPTI <50%: HR=3,0, 95% confidence interval (1,14; 7,92), p=0,026.Conclusion. The developed QFPT and RPTI make it possible to assess the quality of PT and performing a comprehensive assessment of the quality and adherence to PT, respectively. A relationship between low RPTI and a threefold increase in the risk of adverse outcomes in patients with stable exertional angina was revealed.

Publisher

Silicea - Poligraf, LLC

Subject

Cardiology and Cardiovascular Medicine,Education

Reference14 articles.

1. Martsevich SY, Lukina YV, Kutishenko NP, et al., on behalf of the working group of the observational study PRIORITY. Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study). Rational Pharmacotherapy in Cardiology. 2018;14(6):891-900. (In Russ). doi:10.20996/1819-6446-2018-14-6-891-900.

2. Martsevich SYu, Lukina YuV, Kutishenko NP, et al. Treatment adherence and quality of life of patients with stable ischemic heart disease in treatment with nicorandil: interrelation and interaction (according to the results of the observational study NIKEA). Rational Pharmacotherapy in Cardiology. 2018;14(3):408-17. (In Russ.) doi:10.20996/1819-6446-2018-14-3-408-417.

3. Martsevich SY, Lukina YV, Kutishenko NP. Primary Nonadherence to Treatment with New Oral Anticoagulants: The Results of a Prospective Observational Study "ANTEY". Open Cardiovasc Med J. 2021;15:56-61. doi:10.2174/1874192402115010056.

4. Lukina YuV, Dmitrieva NA, Kutishenko NP, et al. The relationship and interinfluence of aspects of therapy safety and compliance in patients with cardiovascular diseases (by the data from outpatient registry "PROFILE"). Cardiovascular Therapy and Prevention. 2018;17(5):72-8. (In Russ.) doi:10.15829/1728-8800-2018-5-72-78.

5. Lukina YuV, Kutishenko NP, Martsevich SYu. Efficacy, safety and long-term outcomes of nicorandil use in patients with stable ischemic heart disease according to the results of randomized and observational studies. Rational Pharmacotherapy in Cardiology. 2019;15(5):641-8. (In Russ.) doi:10.20996/1819-6446-2019-15-5-641-648.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3